CA
NZ
UK
AU
IND
US
ETUARYTM FY26 total revenue guidance is $100.5M-$111M, according to an updated corporate presentation from GYRE Therapeutics, Inc. (NASDAQ: GYRE) made available on September 1, 2026. The presentation positions the company’s China commercial operations alongside a development strategy spanning protein degraders and degrader antibody conjugates.
A new insider position has been recorded for Lewis Sheri at Merit Medical Systems (NASDAQ: MMSI) Inc. where he serves as EVP of Global Operations.
The disclosure identifies PULSE BIOSCIENCES, INC (NASDAQ: PLSE). As the organisation associated with the position and names Teplitsky as its chief operating officer.
Advisers Investment Trust’s Independent Franchise Partners US Equity Fund has removed Michael Allison from its portfolio-manager roster after his retirement from Independent Franchise Partners LLP.
The development gives investors tracking NAZ a named insider connection without attaching a numerical value to the position.
Adicet Bio, Inc. (NASDAQ: ACET) completed the final patient visit for a planned analysis of prulacabtagene leucel, known as prula-cel, in systemic lupus erythematosus patients with or without lupus nephritis. Topline results are expected in September 2026, followed by an investor webcast covering the …
5AM Group Reports CAMP (NASDAQ: CAMP) Position
Medirom Healthcare Technologies Inc. (NASDAQ: MRM) lists Kouji Eguchi as the beneficial owner of 2,031,558 Common Shares, representing 25.11% of the outstanding Common Shares. The ownership is reported under an activist Schedule 13D. The update reflects a stock-option grant dated July 18, 2025, and …
PMV Pharmaceuticals, Inc. (NASDAQ: PMVP) is offering common stock, pre-funded warrants and common stock warrants through a shelf registration permitting aggregate securities sales of up to $200,000,000. Net proceeds are intended to support late-stage clinical development of rezatapopt, regulatory submission and commercialization preparation activities, …
Tenon Medical, Inc. (NASDAQ: TNON) identifies HRT Financial LP as an insider and 10% owner. The reported position is new.
Please wait processing your request...